HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY: ifrs:DilutedEarningsLossPerShare

Value{"amount": 0.84}
Period2022-01-01 – 2022-12-31
Statussuperseded
EntityHIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:549300BNS685UXH4JI75:2023-12-31
Retrieved: 2026-08-24T00:19:57.341023+02:00
Raw response sha256: 405afb5c38619133da701aca0c644ab8…
Cite as: FACTANKER, https://factanker.com/fact/99954e59-e859-4d8d-8494-1b67499d0734

History